BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25046253)

  • 1. miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin.
    Althoff K; Lindner S; Odersky A; Mestdagh P; Beckers A; Karczewski S; Molenaar JJ; Bohrer A; Knauer S; Speleman F; Epple M; Kozlova D; Yoon S; Baek K; Vandesompele J; Eggert A; Schramm A; Schulte JH
    Int J Cancer; 2015 Mar; 136(6):1308-20. PubMed ID: 25046253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A.
    Althoff K; Beckers A; Odersky A; Mestdagh P; Köster J; Bray IM; Bryan K; Vandesompele J; Speleman F; Stallings RL; Schramm A; Eggert A; Sprüssel A; Schulte JH
    Int J Cancer; 2013 Sep; 133(5):1064-73. PubMed ID: 23400681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of miR-214-3p in esophageal squamous cancer cells enhances sensitivity to cisplatin by targeting survivin directly and indirectly through CUG-BP1.
    Phatak P; Byrnes KA; Mansour D; Liu L; Cao S; Li R; Rao JN; Turner DJ; Wang JY; Donahue JM
    Oncogene; 2016 Apr; 35(16):2087-97. PubMed ID: 26234674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-542-3p suppresses cellular proliferation of bladder cancer cells through post-transcriptionally regulating survivin.
    Zhang J; Wang S; Han F; Li J; Yu L; Zhou P; Chen Z; Xue S; Dai C; Li Q
    Gene; 2016 Apr; 579(2):146-52. PubMed ID: 26723509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cyclin-dependent kinase 1-induced cell death in neuroblastoma cells through the microRNA-34a-MYCN-survivin pathway.
    Chen Y; Tsai YH; Tseng SH
    Surgery; 2013 Jan; 153(1):4-16. PubMed ID: 22703967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells.
    Buechner J; Henriksen JR; Haug BH; Tømte E; Flaegstad T; Einvik C
    Differentiation; 2011 Jan; 81(1):25-34. PubMed ID: 20980091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma.
    Haug BH; Henriksen JR; Buechner J; Geerts D; Tømte E; Kogner P; Martinsson T; Flægstad T; Sveinbjørnsson B; Einvik C
    Carcinogenesis; 2011 Jul; 32(7):1005-12. PubMed ID: 21572098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma.
    Maugeri M; Barbagallo D; Barbagallo C; Banelli B; Di Mauro S; Purrello F; Magro G; Ragusa M; Di Pietro C; Romani M; Purrello M
    Oncotarget; 2016 Dec; 7(50):83330-83341. PubMed ID: 27829219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1.
    Creevey L; Ryan J; Harvey H; Bray IM; Meehan M; Khan AR; Stallings RL
    Mol Cancer; 2013 Mar; 12():23. PubMed ID: 23531080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma.
    Buechner J; Tømte E; Haug BH; Henriksen JR; Løkke C; Flægstad T; Einvik C
    Br J Cancer; 2011 Jul; 105(2):296-303. PubMed ID: 21654684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PLAGL2/MYCN/miR-506-3p interplay regulates neuroblastoma cell fate and associates with neuroblastoma progression.
    Zhao Z; Shelton SD; Oviedo A; Baker AL; Bryant CP; Omidvarnia S; Du L
    J Exp Clin Cancer Res; 2020 Feb; 39(1):41. PubMed ID: 32087738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma.
    Shohet JM; Ghosh R; Coarfa C; Ludwig A; Benham AL; Chen Z; Patterson DM; Barbieri E; Mestdagh P; Sikorski DN; Milosavljevic A; Kim ES; Gunaratne PH
    Cancer Res; 2011 Jun; 71(11):3841-51. PubMed ID: 21498633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combined gene expression and functional study reveals the crosstalk between N-Myc and differentiation-inducing microRNAs in neuroblastoma cells.
    Zhao Z; Ma X; Shelton SD; Sung DC; Li M; Hernandez D; Zhang M; Losiewicz MD; Chen Y; Pertsemlidis A; Yu X; Liu Y; Du L
    Oncotarget; 2016 Nov; 7(48):79372-79387. PubMed ID: 27764804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis.
    Chen Y; Stallings RL
    Cancer Res; 2007 Feb; 67(3):976-83. PubMed ID: 17283129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a.
    Chen X; Pan M; Han L; Lu H; Hao X; Dong Q
    FEBS Lett; 2013 Nov; 587(22):3729-37. PubMed ID: 24140344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
    Hu Y; Xu K; Yagüe E
    Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA-337-3p suppresses neuroblastoma progression by repressing the transcription of matrix metalloproteinase 14.
    Xiang X; Mei H; Zhao X; Pu J; Li D; Qu H; Jiao W; Zhao J; Huang K; Zheng L; Tong Q
    Oncotarget; 2015 Sep; 6(26):22452-66. PubMed ID: 26084291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma.
    Swarbrick A; Woods SL; Shaw A; Balakrishnan A; Phua Y; Nguyen A; Chanthery Y; Lim L; Ashton LJ; Judson RL; Huskey N; Blelloch R; Haber M; Norris MD; Lengyel P; Hackett CS; Preiss T; Chetcuti A; Sullivan CS; Marcusson EG; Weiss W; L'Etoile N; Goga A
    Nat Med; 2010 Oct; 16(10):1134-40. PubMed ID: 20871609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel anthranilamide-pyrazolo[1,5-a]pyrimidine conjugates modulate the expression of p53-MYCN associated micro RNAs in neuroblastoma cells and cause cell cycle arrest and apoptosis.
    Ramaiah MJ; Pushpavalli SN; Lavanya A; Bhadra K; Haritha V; Patel N; Tamboli JR; Kamal A; Bhadra U; Pal-Bhadra M
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5699-706. PubMed ID: 23992861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep MicroRNA sequencing reveals downregulation of miR-29a in neuroblastoma central nervous system metastasis.
    Cheung IY; Farazi TA; Ostrovnaya I; Xu H; Tran H; Mihailovic A; Tuschl T; Cheung NK
    Genes Chromosomes Cancer; 2014 Oct; 53(10):803-14. PubMed ID: 24898736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.